CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- 4 Grant or award Director acquired 686 shares (grant or award)
- 4 Grant or award Director acquired 686 shares (grant or award)
- 4 Grant or award Director acquired 686 shares (grant or award)
- 4 Grant or award Director acquired 686 shares (grant or award)
- 4 Shares withheld for taxes Senior VP, R&D gave up 710 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 334 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 710 shares (to pay taxes)
- 4 Open-market buy Director bought 1,500 shares at an average $158.84 ($238,260)
- 3/A Insider 3/A
- 4 Shares withheld for taxes Chief Operating Officer gave up 334 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 3,674 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 1,247 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 126 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 8,244 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 210 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 9,418 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 1,090 shares (to pay taxes)
- 4 Shares withheld for taxes Senior VP, R&D gave up 358 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 521 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 594 shares (to pay taxes)
Page 8 of 34 · 669 filings